DSM is building a portfolio of transformative technologies and services to
revolutionize existing biopharmaceutical manufacturing processes.
DSM Biologics offers world-class technologies and manufacturing services to
the biopharmaceutical market, incorporating mammalian cell lines as production
platforms for recombinant proteins and monoclonal antibodies. We can provide a
turnkey biologic manufacturing solution that reduces cost, risk and
time-to-market.